SC

Schrodinger

SDGR
NASDAQHealth Care

Recent Patents

sdgr
over 1 year ago

Filed a patent for "src inhibitors and uses thereof" on Tue, May 16, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "cbl-b modulators and uses thereof" on Mon, December 19, 2022

New US Patent
sdgr
over 1 year ago

Filed a patent for "azaindazoles as jak2 inhibitors" on Fri, January 6, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "heterocyclics as egfr inhibitors" on Thu, March 2, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "cbl-b modulators and uses thereof" on Mon, November 20, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "forms and compositions of a jak2 inhibitor" on Wed, May 3, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "compounds and compositions for treating conditions associated with apj receptor activity" on Tue, May 23, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "compounds and compositions for treating conditions associated with apj receptor activity" on Thu, October 10, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "novel protease inhibitors for treatment of coronavirus infections" on Tue, September 13, 2022

New US Patent
sdgr
over 1 year ago

Filed a patent for "cbl-b modulators and uses thereof" on Tue, October 11, 2022

New US Patent
sdgr
over 1 year ago

Filed a patent for "inhibitors of av ß6 integrin" on Thu, July 13, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "inhibitors of (alpha-v)(beta-6) integrin" on Thu, July 13, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors" on Thu, June 1, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "methods and systems for calculating free energy differences using a modified bond stretch potential" on Thu, August 17, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "shp2 phosphatase inhibitors and methods of use thereof" on Thu, July 27, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "tyk2 inhibitors and uses thereof" on Thu, December 7, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease" on Thu, September 14, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "hpk1 antagonists and uses thereof" on Thu, January 25, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "ubiquitin-specific protease 7 (usp7) inhibitors and uses thereof" on Thu, May 16, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "cbl-b modulators and uses thereof" on Thu, September 28, 2023

New US Patent
sdgr
over 1 year ago

Filed a patent for "substituted pyrrolo[3,4-c]pyridines as hpk1 antagonists" on Thu, June 13, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "antagonists of human integrin (alpha4)(beta7)" on Thu, September 5, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "hpk1 antagonists and uses thereof" on Thu, June 20, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "indole compounds and methods of use" on Thu, August 22, 2024

New US Patent
sdgr
over 1 year ago

Filed a patent for "conjugates comprising antifungals and heat shock protein 90 (hsp90) inhibitors and methods of use thereof" on Thu, April 18, 2024

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...